Berzelius Clinical Research Center Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2009
NCT00860080
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Berzelius Clinical Reseach Centre

Active Ingredients

Drugs in Phase 1 Trials (3)

azd9668 (1 trial)

hyaluronic acid (1 trial)

warfarin (coumadin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tissue Adhesions (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 3